<Disease><Name>SIALIDOSIS TYPE II</Name><Synonym>NEURAMINIDASE DEFICIENCY; MUCOLIPIDOSIS I</Synonym><OMIM><Number>256550</Number><URL>http://omim.org/entry/256550</URL></OMIM><Orphanet><Number>87876</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=87876</URL></Orphanet><Protein><Number>Sialidase 1</Number><URL>http://www.uniprot.org/uniprot/Q99519</URL></Protein><ExPASy><Number>3.2.1.18</Number><URL>http://enzyme.expasy.org/EC/3.2.1.18</URL></ExPASy><Gene>6p21.33</Gene><ICD>E77.1</ICD><Summary>rare ;autosomal recessive;- type I: milder, late-onset, normosomatic form ;- type II: severe, early-onset form</Summary><Symptoms><symtomp><id>2341</id><symptom>angiokeratoma</symptom><category>CARDIOVASCULAR SYSTEM | SKIN</category></symtomp><symtomp><id>1738</id><symptom>ascites</symptom><category>BODY | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1877</id><symptom>cardiomegaly</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1733</id><symptom>cherry-red spot on retinal macula</symptom><category>EYES</category></symtomp><symtomp><id>1761</id><symptom>coarse facial features</symptom><category>HEAD</category></symtomp><symtomp><id>2448</id><symptom>corneal clouding</symptom><category>EYES</category></symtomp><symtomp><id>3819</id><symptom>developmental delay</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2227</id><symptom>dysmorphism / dysmorphic features</symptom><category>HEAD</category></symtomp><symtomp><id>2302</id><symptom>dysostosis multiplex</symptom><category>SKELATAL DEFECT</category></symtomp><symtomp><id>2216</id><symptom>edema</symptom><category>SKIN</category></symtomp><symtomp><id>2256</id><symptom>EMG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3358</id><symptom>exaggerated startle reflex</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2428</id><symptom>hernia</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2356</id><symptom>hydrops fetalis</symptom><category>GENERAL TOPICS | IMMUNE OR HEMATOLOGIC SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2603</id><symptom>lens opacities</symptom><category>EYES</category></symtomp><symtomp><id>1887</id><symptom>macrocephaly (large calvaria, &gt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2349</id><symptom>night blindness / nyctalopia</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1769</id><symptom>prominent abdomen / protuberant abdomen</symptom><category>BODY | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2461</id><symptom>renal failure, acute/chronic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2042</id><symptom>splenomegaly (large spleen)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2123</id><symptom>tubulopathy / renal tubulopathy</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2447</id><symptom>vertebral changes or anomalies</symptom><category>BODY | SKELATAL DEFECT</category></symtomp></Symptoms><Metabolites><metabolite><id>694</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>400.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>309</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>150.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>308</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>60.00</min><max>400.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>947</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>25.00</min><max>90.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>889</id><name>Sialyloligosaccharides</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>4956</id><title>Sialidoses</title><author>Franceschetti S,</author><journal>Epileptic Disord</journal><year>2016</year><book /><volume>18</volume><number>22</number><pages>89-93</pages><co_aut>Canafoglia L</co_aut></literature><literature><id>4957</id><title>Type II sialidosis: review of the clinical spectrum and identification of a new splicing defect with chitotriosidase assessment</title><author>Caciotti A,</author><journal>J Neurol</journal><year>2009</year><book /><volume>256</volume><number>11</number><pages>1911-1915</pages><co_aut>et al.</co_aut></literature><literature><id>2028</id><title>Progressive myoclonic epilepsy</title><author>Zupanc ML</author><journal>Cerebellum</journal><year>2004</year><book /><volume>3</volume><number>3</number><pages>156-171</pages><co_aut>Legros B</co_aut></literature><literature><id>2025</id><title>Molecular pathology of NEU1 gene in sialidosis</title><author>Seyrantepe V</author><journal>Hum Mutat</journal><year>2003</year><book /><volume>22</volume><number>5</number><pages>343-352</pages><co_aut>et al.</co_aut></literature><literature><id>2026</id><title>[Mucolipidoses type II. Case report]</title><author>Aracena M</author><journal>Rev Med Chil</journal><year>2003</year><book /><volume>131</volume><number>3</number><pages>314-319</pages><co_aut>et al.</co_aut></literature><literature><id>2027</id><title>Clinical variability of type II sialidosis by C808T mutation</title><author>Rodriguez Criado G</author><journal>Am J Med Genet A</journal><year>2003</year><book /><volume>116</volume><number>4</number><pages>368-371</pages><co_aut>et al.</co_aut></literature><literature><id>2029</id><title>Spinal anesthesia for a patient with type I sialidosis undergoing abdominal surgery</title><author>Tran QH</author><journal>Acta Anaesthesiol Scand</journal><year>2001</year><book /><volume>45</volume><number>7</number><pages>919-921</pages><co_aut>et al.</co_aut></literature><literature><id>97</id><title>Disorders of glycoprotein degradation and structure: alpha-mannosidosis, beta-mannosidosis, fucosidosis, sialidosis, aspartylglucosminuria and carbohydrate- deficient glycoprotein syndrome</title><author>Thomas GH</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>2</volume><number>0</number><pages>2529-2561</pages><co_aut>Beaudet AL</co_aut></literature></Literatures></Disease>